TN Law Flashcards
Where a LOCAL health department does NOT employ a pharmacist what happens
All inventory controls, accountability, repackaging, security, storage and distribution of such drugs shall be under the supervision of a pharmacist at the REGIONAL level, as defined by the Department of Health.
According to Tennessee State Pharmacy Law, any INSULIN preparation shall be:
(1) . dispensed only by OR under the supervision of a pharmacist and
(2) . must be properly stored in an area NOT accessible to the general public
A drug shall be classified as MISBRANDED if:
(1). Its LABELING → is FALSE or MISLEADING in any particular way.
(2). It is in a pre-PACKAGE FORM, → UNLESS it bears a LABEL containing:
→ a). the NAME & PLACE of BUSINESS of the manufacturer, packer, or distributor; &
→ b). an accurate statement of the QUANTITY of the contents in terms of weight, measure, or numerical count.
(3). Any word, statement, or other information to appear on the LABEL that is in such terms as TO RENDER it likely to be read & understood by the ordinary individual under customary conditions of purchase and use.
(4). It is a drug & its CONTAINER →
→ a). is so made, formed, or filled as to be MISLEADING; or
→ b). It is an IMITATION of another drug; or
→ c). It is offered FOR SALE UNDER ANOTHER the NAME of ANOTHE DRUG
(5) . It is DANGEROUS TO HEALTH → when used in the dosage or manner; or with the frequency or duration prescribed, recommended, or SUGGESTED IN THE LABELING thereof.
(6) . It is a COLOR ADDITIVE → that is used for ANY OTHER PURPOSES other than being a color additive
(7) . NOT REGISTERED with FDCA→ It was manufactured, prepared, propagated, compounded, or processed in an establishment in any State NOT duly registered under section 510 of FDCA.
“[Schedule II]” Controlled prescriptions for patients in a LTCF or patients with a medical diagnosis documenting a terminal illness are valid for a period not to exceed:
60 days from the issue date
The partial filling of a prescription for a Controlled Substance listed in “[Schedule II]” is permissible if the pharmacist is unable to supply the full quantity called for in a written or emergency oral prescription and he makes “a notation of the quantity supplied” on
(1). the FACE of the written prescription, (2). written record of the emergency oral prescription, or (3). in the electronic prescription record.
The REMAINING PORTION of the prescription may be filled WITHIN 72 Hours (3 DAYS) of the FIRST PARTIAL FILLING; HOWEVER, if the remaining portion is not or CANNOT BE FILLED within the 72-hour period, the pharmacist shall NOTIFY THE PRESCRIBING Individual practitioner.
NO FURTHER QUANTITY MAY BE SUPPLIED → beyond 72 hours without a NEW Prescription.
A prescription for a “[Schedule II]” Controlled Substance written for a patient in a Long Term Care Facility (LTCF) or for a patient with a medical diagnosis documenting a TERMINAL ILLNESS MAY BE FILLED IN:
“Partial Quantities” → to include “Individual Dosage Units”.
If there is any question whether a patient may be classified as having a TERMINAL ILLNESS, the pharmacist must contact the practitioner PRIOR to PARTIALLY FILLING the prescription.
BOTH the Pharmacist + Prescribing Practitioner → have a corresponding responsibility to assure that the Controlled Substance is for a TERMINAL ILL PATIENT.
The Pharmacist MUST RECORD on the prescription whether the patient is TERMINAL ILL or an “LTCF patient.” A prescription that is PARTIALLY FILLED and does not contain the notation “terminally ill” or “LTCF patient” shall be deemed to have been filled in violation of the Act.
or EACH PARTIAL FILLING, the Dispensing Pharmacist shall record on the BACK of the prescription (or on another appropriate record, uniformly maintained, and readily retrievable) the
(1). date of the partial filling, (2). quantity dispensed, (3) remaining quantity authorized to be dispensed, and (4). the identification of the dispensing pharmacist.
If the prescription is written for an animal, what is required on the prescription?
If the prescription is for an animal, the prescription shall state the species of animal for which the drug is prescribed and the full name and address of the owner of the animal.
No drug product may be dispensed unless the prescription label discloses the:
(1). brand name & strength, or
(2). the generic name, strength, & manufacturer / distributor of the drug product dispensed
[unless the prescribing practitioner requests omission of the above information.]
notification of change of address or primary practice site within:
IMMEDIATELY!
If a pharmacist, pursuant to a prescription order that specifies a drug product by its brand name, dispenses the drug product equivalent of the drug product specified in the prescription order, the prescription label must include
BOTH the generic name of the drug product equivalent AND the brand name specified in the prescription order, (unless the prescribing practitioner requests that the brand name be omitted from the label).
A PHARMACIST convicted of any crime, including driving under the influence of alcohol or Controlled Substances, shall report such conviction to the BOARD within
ten (10) days of the conviction becoming FINAL.
According to Tennessee State Pharmacy Law, the prescription record should be kept on file for:
two years from date of dispensing; Each medical and prescription order when dispensed shall be serially numbered, filed numerically & maintained so as to be readily retrievable at the pharmacy practice site for at least two (2) years from the date the medical and prescription order was LAST DISPENSED.
INSTITUTIONAL Pharmacies shall NOT BE REQUIRED to “serially number” medical and prescription orders dispensed for administration to inpatients of that institution.
The patient profile system must contain a complete and accurate record of:
Each such profile must be maintained so as to be readily retrievable at the pharmacy practice site for at least:
a. the refill history of all medical and prescription orders dispensed at the pharmacy practice site.
b. two (2) years from the date of the last dispensing recorded on the profile.
Application for registration as a Narcotic Treatment Program is made using what form
DEA Form 363
Practitioners wishing to Administer & Dispense APPROVED “[Schedule II]” Controlled Substance [that is, Methadone] for Maintenance & Detoxification treatment must obtain:
- a separate DEA registration as a Narcotic Treatment Program
- APPROVAL & REGISTRATION of the: a. Center for Substance Abuse Treatment [CSAT] Department of Health and Human Services (HHS), as well as the b. the applicable State Methadone Authority
(4) . If a practitioner chooses to DISPENSE controlled substances, → the practitioner must maintain, separate from all other records, for a period of at least TWO (2) YEARS, all required records of receipt, storage, and distribution.
If a practitioner chooses to PRESCRIBE these controlled substances, → the practitioner must utilize their Unique Identification Number on the prescription in addition to his/her regular DEA registration number.
(5). An EXCEPTION to the registration requirement, known as the “[three day rule]”, allows a practitioner who is not separately registered as a narcotic treatment program, to administer (but not prescribe) narcotic drugs to a patient for the purpose of relieving acute withdrawal symptoms while arranging for the patient’s referral for treatment, under the following conditions:
→ a. Not more than one day’s medication may be administered or given to a patient at one time;
→ b. This treatment may not be carried out for more than 72 hours &;
→ c. This 72-hour period cannot be renewed or extended.
(6). The 72-hour exception offers an opioid dependent individual relief from experiencing acute withdrawal symptoms, while the physician arranges placement in a maintenance/detoxification treatment program. This provision was established to augment, not to circumvent, the separate registration requirement.
If a practitioner wishes to prescribe, administer, or dispense “[Schedule III, IV, or V]” Controlled Substances approved for addiction treatment (i.e., buprenorphine drug products), the practitioner must request:
a waiver (Form SMA-167) & fulfill the requirements of CSAT. If DEA approves this waiver, the practitioner will receive a → Unique Identification Number.
A C 2 Rx comes in with other non controls on the same prescription what should happen?
(a) . Pharmacists, pharmacy interns & pharmacy technicians may transfer a prescription containing a “[Schedule II]” Controlled Substance with any other drug that is a NON-Scheduled prescription drug to another prescription form under Tennessee Pharmacy Practice Act.
(b) . The transfer authorized in subsection (a) may be accomplished by scanning, photocopying or transcribing, by hand or other means, and shall include all information regarding each drug or supply being transferred.
(c) . The prescription generated in a pharmacy by the transfer process shall NOT BE REQUIRED to be on tamper-resistant prescription paper.
(d) . The prescription generated in a pharmacy utilizing the transfer process shall be recognized as a VALID, LEGAL prescription order and shall serve as the ORIGINAL PRESCRIPTION for recordkeeping and other purposes.
In Tennessee, inventory records must be maintained for a period of at least:
2 years
Inventory records must contain
(1) . the NAME & ADDRESS of the pharmacy practice site;
(2) . the NAME, STRENGTH, DOSAGE FORM, & QUANTITY of each Controlled Substance ON HAND;
(3) . the DATE OF INVENTORY; and
(4) . whether the inventory was taken as of the OPENING OR CLOSE of business on that date.
A prescription for Buprenorphine prescribed for addiction requires which of the following on the prescription?
x DEA number
Central fill pharmacies shall NOT BE AUTHORIZED to prepare prescriptions for a controlled substance listed in what category upon receiving an oral authorization from a RETAIL pharmacist “or” an individual practitioner.
schedule 2
A Pharmacist MAY DISCLOSE patient information to a third party WITHOUT the patient’s consent in the following situations:
(1) . When a pharmacist is performing PROSPECTIVE DUR.
(2) . To assist prescribers in obtaining a comprehensive drug history on a patient.
(3) . To prevent abuse or misuse of any drug or device and the diversion of Controlled Substances.
(4) . Provide a MEDICATION THERAPY MANAGEMENT program or a quality assurance program.
Under Tennessee State Pharmacy Law, a RECORD of the DESTRUCTION of Controlled Substances previously dispensed to or for patients shall be maintained so as to be readily retrievable for at least:
and should include:
two years
(1) . the IDENTIFICATION of PATIENT;
(2) . the NAME, STRENGTH, DOSAGE form, & QUANTITY of each the drug
(3) . the DATE & METHOD of destruction; &
(4) . the IDENTIFICATION of AUTHORIZED PERSONNEL WITNESSING the destruction & its record